Neuvasq Biotechnologies SA
9.3 FTENeuvasq Biotechnologies reported total assets of €7.23m at the end of the 2025 financial year (annual accounts filed with the NBB on 23 Jun 2026), with 9.3 full-time equivalents.
By total assets for 2025, Neuvasq Biotechnologies ranks among the 2,000 largest of the 50,410 companies in its sector (NACE 7020) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Neuvasq Biotechnologies shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +84 % Total assets +95 % Headcount (avg FTE) +221 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Neuvasq Biotechnologies's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 23 Jun 2026
- Year ended 31 Dec 2024filed on 13 Oct 2025
- Year ended 31 Dec 2023filed on 15 Jul 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 22 Aug 2022
Neuvasq Biotechnologies's financial analysis
- Solvency87.3%sector median: 50.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Neuvasq Biotechnologies
15 active director(s) in the register.
and 9 more
Neuvasq Biotechnologies's shareholders and holdings →Neuvasq Biotechnologies's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0762.966.663
- VAT number
- BE0762966663
- Peppol
- Registered · 0208:0762966663 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 05 Feb 2021
- Registered office
- 6041 Charleroi
- Size
- Micro · 9.3 FTE
- Latest accounts
- 2025 · filed on 23 Jun 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
Neuvasq Biotechnologies (SA) has been based in Charleroi since 2021, active in: business and other management consultancy activities. For 2025, it reports a net loss of €2.60m and equity of €6.31m; its revenue is not published. With 9.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 87.3%, above the median of its sector (50.1%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Neuvasq Biotechnologies
Companies in the same business, of comparable size and area, outside its group.
- Sicher Research and experimental development on natural sciences and engineering Balen · balance sheet 246,186 €
- PharmaFluidics Research and experimental development on natural sciences and engineering Ghent · balance sheet €16.4m
- Neurologie AZORG Research and experimental development on natural sciences and engineering Aalst · balance sheet 759,096 €
- Apr. Biol. Inger Brandt Research and experimental development on natural sciences and engineering Lebbeke · balance sheet €2.44m
- Centre d'innovation médicale Michel Cremer/Marie Curie Research and experimental development on natural sciences and engineering Montigny-le-Tilleul · balance sheet €1.53m
- Nutrition Sciences Technical testing and analysis Ghent · balance sheet €1.61m
- Koios Care Research and experimental development on natural sciences and engineering Antwerp · balance sheet €1.01m
- FADI Research and experimental development on natural sciences and engineering Ghent · balance sheet €1.42m
Frequently asked questions about Neuvasq Biotechnologies
What is the revenue of Neuvasq Biotechnologies?
Neuvasq Biotechnologies files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Neuvasq Biotechnologies?
In Belgium, the VAT number is the company number prefixed with BE: BE0762966663 for Neuvasq Biotechnologies, if the company is VAT-registered. Its company number (CBE) is 0762.966.663.
Where is the registered office of Neuvasq Biotechnologies?
According to the CBE register, the registered office of Neuvasq Biotechnologies is in 6041 Charleroi.
What is the equity of Neuvasq Biotechnologies?
At the close of the 2025 financial year, the equity of Neuvasq Biotechnologies amounts to 6,308,765 €, a solvency of 87.3% of total assets.
How many people work at Neuvasq Biotechnologies?
9.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Neuvasq Biotechnologies?
The register lists 15 active mandates at Neuvasq Biotechnologies. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Neuvasq Biotechnologies within its sector?
By total assets for 2025, Neuvasq Biotechnologies ranks among the 2,000 largest of the 50,410 companies in its sector (NACE 7020) in Belgium that filed accounts for that financial year.
The full file of Neuvasq Biotechnologies
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →